🇺🇸 FDA
Patent

US 8609661

Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor

granted A61KA61K31/407A61K31/495

Quick answer

US patent 8609661 (Pyrimido-pyrrolo-quinoxalinedione inhibitors of cystic fibrosis transmembrane conductance regulator protein and uses therefor) held by The Regents of the University of California expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/407, A61K31/495, A61P, A61P1/00